The Molecular Targeted Therapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Molecular Targeted Therapy Market?
The market size of the molecular targeted therapy has seen a robust increase in recent years. The growth is expected to rise from $65.78 billion in 2024 to $71.64 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Molecular Targeted Therapy Industry?
The Molecular Targeted Therapy market is predicted to reach $99.4 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.5%.
Download Your Free Sample of the 2025 Molecular Targeted Therapy Market Report and Uncover Key Trends Now!
Global Market Segmentation: Identifying Major Molecular Targeted Therapy Industry Segments
The molecular targeted therapy market covered in this report is segmented –
1) By Therapy Type: Monoclonal Antibodies, Small Molecule Inhibitors, Gene Therapy, Cell Therapy
2) By Mode Of Administration: Oral, Injectable, Topical, Intravenous
3) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Other Applications
4) By End-User: Hospitals, Clinics, Research Laboratories, Diagnostic Centers
What are the Key Growth Drivers Fueling the Molecular Targeted Therapy Market?
The key drivers in the molecular targeted therapy marketare:
• Growing investment in cancer research and targeted immunotherapies
• Expansion of clinical trial activities in precision medicine
• Rising use of companion diagnostics
• Improved healthcare accessibility in emerging economies
Pre-order the 2025 Molecular Targeted Therapy Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Molecular Targeted Therapy Market?
The key trends in the molecular targeted therapy market are:
• The market is seeing major technological advancements in genomics.
• There is a rise in innovative drug delivery systems.
• Increased investment in research and development is a significant trend.
• Developments in molecular diagnostics and adoption of AI technology for therapy discovery are emerging trends.
Who Are the Top Competitors & Leading Players in the Molecular Targeted Therapy Market?
Major companies in the molecular targeted therapy market are:
• Pfizer Inc.
• Merck & Co. Inc.
• AbbVie Inc.
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Amgen Inc.
• Regeneron Pharmaceuticals
• Vertex Pharmaceuticals Incorporated
• Novartis AG
• Incyte Corporation
• Exelixis Inc.
• IDEAYA Biosciences Inc.
• Prelude Therapeutics Incorporated
• Gamida Cell Ltd.
• Adaptimmune Therapeutics plc
• Engine Biosciences Pte. Ltd.
• Krystal Biotech Inc.
• Sotio Biotech a.s.
• Cybrexa Therapeutics Inc.
Regional Dominance: Which Area Leads the Global Molecular Targeted Therapy Market?
North America was the largest region in the molecular targeted therapy market in 2024
